Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -54.12% is in line with its 5-year average of -52.45%, around the middle of its 5-year range (-90.02%–-32.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.94% above its 12-month average of -64.39%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -54.12%.
RETURN ON INVESTED CAPITAL (ROIC)
-54.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-64.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-61.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-52.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+15.94%
CURRENT VS 3Y AVG
+11.61%
CURRENT VS 5Y AVG
-3.19%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-51.77%
vs the sector median at left
Solid Biosciences Inc.
Market Cap
$681.27M
Return on Invested Capital (ROIC)
-54.12%
TTM Avg
-64.39%
3Y Avg
-61.23%
5Y Avg
-52.45%
Market Cap
$681.02M
Return on Invested Capital (ROIC)
-118.97%
TTM Avg
-130.14%
3Y Avg
-108.49%
5Y Avg
-89.69%
Market Cap
$685.49M
Return on Invested Capital (ROIC)
-41.63%
TTM Avg
-2189.24%
3Y Avg
-1224.39%
5Y Avg
-874.41%
Market Cap
$673.41M
Return on Invested Capital (ROIC)
1.97%
TTM Avg
18.16%
3Y Avg
11.04%
5Y Avg
1.26%
Market Cap
$691.79M
Return on Invested Capital (ROIC)
-50.92%
TTM Avg
-35.84%
3Y Avg
-41.63%
5Y Avg
-32.97%
Market Cap
$693.19M
Return on Invested Capital (ROIC)
-110.62%
TTM Avg
-99.41%
3Y Avg
-74.42%
5Y Avg
-73.36%
Market Cap
$693.61M
Return on Invested Capital (ROIC)
-42.94%
TTM Avg
-42.70%
3Y Avg
-94.89%
5Y Avg
-93.87%
Market Cap
$694.79M
Return on Invested Capital (ROIC)
-12.00%
TTM Avg
-7.53%
3Y Avg
-5.45%
5Y Avg
-2.27%
Market Cap
$666.95M
Return on Invested Capital (ROIC)
-73.27%
TTM Avg
-60.64%
3Y Avg
-63.77%
5Y Avg
-62.42%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | $681.27M | -54.12% | -64.39% | -61.23% | -52.45% |
| Verastem, Inc. (VSTM)vs › | $681.02M | -118.97% | -130.14% | -108.49% | -89.69% |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | -41.63% | -2189.24% | -1224.39% | -874.41% |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 1.97% | 18.16% | 11.04% | 1.26% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | -50.92% | -35.84% | -41.63% | -32.97% |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | -110.62% | -99.41% | -74.42% | -73.36% |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | -42.94% | -42.70% | -94.89% | -93.87% |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | -12.00% | -7.53% | -5.45% | -2.27% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | -73.27% | -60.64% | -63.77% | -62.42% |
| Annexon, Inc. (ANNX)vs › | $660.29M | -101.43% | -70.16% | -61.78% | -52.46% |
ROIC
-54.1%
ROE
-55.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -54.12% |
| 2026-03-31 | -50.04% |
| 2025-12-31 | -90.02% |
| 2025-09-30 | -71.43% |
| 2025-06-30 | -56.32% |
| 2025-03-31 | -45.35% |
| 2024-12-31 | -81.90% |
| 2024-09-30 | -59.32% |
| 2024-06-30 | -46.25% |
| 2024-03-31 | -42.28% |
| 2023-12-31 | -69.31% |
| 2023-09-30 | -69.00% |
| 2023-06-30 | -60.67% |
| 2023-03-31 | -54.04% |
| 2022-12-31 | -44.78% |
| 2022-09-30 | -54.04% |
| 2022-06-30 | -46.81% |
| 2022-03-31 | -43.45% |
| 2021-12-31 | -34.61% |
| 2021-09-30 | -33.10% |
| 2021-06-30 | -32.12% |
| 2021-03-31 | -29.88% |
| 2020-12-31 | -60.27% |
| 2020-09-30 | -385.93% |
| 2020-06-30 | -240.83% |
| 2020-03-31 | -189.71% |
| 2019-12-31 | -140.05% |
| 2019-09-30 | -95.79% |
| 2019-06-30 | -119.57% |
| 2019-03-31 | -85.19% |
| 2018-12-31 | -59.54% |
| 2018-09-30 | -46.84% |
| 2018-06-30 | -38.70% |
| 2018-03-31 | -31.63% |
| 2017-12-31 | -84.50% |
| 2017-09-30 | -205.21% |
